Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

MLA

Morschhauser, Franck, et al. Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f3989a335983ccc37800421665ae98b9&authtype=sso&custid=ns315887.

APA

Morschhauser, F., Fowler, N. H., Feugier, P., Bouabdallah, R., Tilly, H., Palomba, M. L., Fruchart, C., Libby, E. N., Casasnovas, R.-O., Flinn, I. W., Haioun, C., Maisonneuve, H., Ysebaert, L., Bartlett, N. L., Bouabdallah, K., Brice, P., Ribrag, V., Daguindau, N., Le Gouill, S., … Zinzani PL. (2018). Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

Chicago

Morschhauser, Franck, Nathan H Fowler, Pierre Feugier, Reda Bouabdallah, Hervé Tilly, M Lia Palomba, Christophe Fruchart, et al. 2018. “Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f3989a335983ccc37800421665ae98b9&authtype=sso&custid=ns315887.